Company News
Gland Pharma Receives USFDA Approval for Sugammadex Injection
Gland Pharma received USFDA approval for its Abbreviated New Drug Application for Sugammadex Injection in two dosage strengths.
The product is bioequivalent to Merck's BRIDION® and is indicated for re
